InvestorsHub Logo
Followers 0
Posts 34
Boards Moderated 0
Alias Born 12/29/2004

Re: read_this_n0w post# 3284

Friday, 11/03/2006 6:03:23 PM

Friday, November 03, 2006 6:03:23 PM

Post# of 6489
- 5-10 % could be easily 25 % for all we know.
- MMD market entrance at least 4 years away, if ever.

INSM is currently definetely not taking the whole primary IGF defiency market. Endo's still interested in TRCA product.

Definetely more dilution in the future to finance broader indications. Nice products, nice prospects for the company despite the trial issues, but not much permanent upside for the stock in the short term, the way I see it.

Nice trading on some good news and then settling down again.

Please don't hype this stock too much, it's not very credible

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INSM News